Correction: Chromosome instability modulated by BMI1-AURKA signaling drives progression in head and neck cancer (Cancer Research (2013) 73 (953-966) DOI: 10.1158/0008-5472.CAN-12-2397);Chromosome instability modulated by BMI1-AURKA signaling drives progression in head and neck cancer

Cancer Research

Volumn 73, Issue 2, 2013, Pages 953-966

  Chou, Chun Hung ^a   Yang, Neng Kai ^a   Liu, Ting Yun ^a   Tai, Shyh Kuan ^f   Hsu, Dennis Shin Shian ^a   Chen, Ya Wei ^f   Chen, Yann Jang ^c   Chang, Cheng Chi ^g   Tzeng, Cheng Hwai ^e   Yang, Muh Hwa ^a,b,d,e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b Institute of Biotechnology in Medicine   (Taiwan)

^c Institute of Genomic Sciences   (Taiwan)

^d Cancer Research Center   (Taiwan)

^e Division of Hematology and Oncology Department of Internal Medicine   (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; BETA CATENIN; BMI1 PROTEIN; POLYCOMB GROUP PROTEIN; PROTEIN KINASE B; PROTEIN P53; TCF4 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG;

ANEUPLOIDY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIAPOPTOSIS; ARTICLE; AURKA GENE; BMI1 GENE; CANCER GROWTH; CANCER PROGNOSIS; CELL CYCLE PROGRESSION; CELL FUNCTION; CENTROSOME; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; GENE REPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION;

EID: 84872566499     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-17-1171     Document Type: Erratum

References (43)

1. Clarke MF, Dickm J, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006;66: 9339-44.
2. Pavet V, Portal MM, Moulin JC, Herbrecht R, Gronemeyer H. Toward novel paradigms for cancer therapy. Oncogene 2011;30: 1-20.
3. Richly H, Aloia L, Di Croce L. Roles of the Polycomb group proteins in stem cells and cancer. Cell Death Dis 2011;2:e204.
4. Sauvageau M, Sauvageau G. Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell 2010;7: 299-313.
5. Iwama A, Oguro H, Negishi M, Kato Y, Morita Y, Tsukui H, et al. Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity 2004;1: 843-51.
6. Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003;425: 962-7.
7. Sangiorgi E, Capecchi MR. Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet 2008;40: 915-20.
8. Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 1999;13: 2678-90.
9. Chiba T, Miyagi S, Saraya A, Aoki R, Seki A, Morita Y, et al. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma. Cancer Res 2008;68: 7742-9.
10. Leung C, Lingbeek M, Shakhova O, Liu J, Tanger E, Saremaslani P, et al. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 2004;428: 337-41.
11. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 2007;104: 973-8.
12. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 2009;11: 1487-95.
13. Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY, Yang WH, et al. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol 2010;12: 982-92.
14. Song LB, Li J, Liao WT, Feng Y, Yu CP, Hu LJ, et al. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 2009;119: 3626-36.
15. Schvartzman JM, Sotillo R, Benezra R. Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer 2010;10: 102-15.
16. Choi CM, Seo KW, Jang SJ, Oh YM, Shim TS, Kim WS, et al. Chromosomal instability is a risk factor for poor prognosis of adenocarcinoma of the lung: fluorescence in situ hybridization analysis of paraffinembedded tissue from Korean patients. Lung Cancer 2009;64: 66-70.
17. Walther A, Houlston R, Tomlinson I. Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 2008;57: 941-50.
18. Carmena M, Earnshaw WC. The cellular geography of aurora kinases. Nat Rev Mol Cell Biol 2003;4: 842-54.
19. Meraldi P, Honda R, Nigg EA. Aurora kinases link chromosome segregation and cell division to cancer susceptibility. Curr Opin Genet Dev 2004;14: 29-36.
20. Gautschi O, Heighway J, Mack PC, Purnell PR, Lara PN Jr, Gandara DR. Aurora kinases as anticancer drug targets. Clin Cancer Res 2008;14: 1639-48.
21. Cammareri P, Scopelliti A, Todaro M, Eterno V, Francescangeli F, Moyer MP, et al. Aurora-A is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells. Cancer Res 2010;70: 4655-65.
22. Katayama H, Sasai K, Kawai H, Yuan ZM, Bondaruk J, Suzuki F, et al. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet 2004;36: 55-62.
23. Wong YK, Chang KW, Chen CF, Chang CS. Characterization of two new cell lines derived from oral cavity human squamous cell carcinomas - OC1 and OC2. J Oral Maxillofac Surg 1990;48: 385-90.
24. Yang WH, Lan HY, Huang CH, Tai SK, Tzeng CH, Kao SY, et al. RAC1 activation mediates Twist1-induced cancer cell migration. Nat Cell Biol 2012;14: 366-74.
25. Tanaka M, Ueda A, Kanamori H, Ideguchi H, Yang J, Kitajima S, et al. Cell-cycle-dependent regulation of human aurora A transcription is mediated by periodic repression of E4TF1. J Biol Chem 2002;277: 10719-26.
26. Remmele W, Schicketanz KH. Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS). Pathol Res Pract 1993;189: 862-6.
27. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000;24: 227-35.
28. Valk-Lingbeek ME, Bruggeman SW, van Lohuizen M. Stem cells and cancer; the polycomb connection. Cell 2004;118: 409-18.
29. Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, et al. Epigenetic stem cell signature in cancer. Nat Genet 2007;39: 157-8.
30. Wu D, Pan W. GSK3: a multifaceted kinase in Wnt signaling. Trends Biochem Sci 2010;35: 161-8.
31. Dutta-Simmons J, Zhang Y, Gorgun G, Gatt M, Mani M, Hideshima T, et al. Aurora kinase A is a target of Wnt/beta-catenin involved in multiple myeloma disease progression. Blood 2009;114: 2699-708.
32. Shitashige M, Hirohashi S, Yamada T. Wnt signaling in the nucleus. Cancer Sci 2008;99: 631-7.
33. Chang CJ, Yang JY, Xia W, Chen CT, Xie X, Chao CH, et al. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-b-catenin signaling. Cancer Cell 2011;19: 86-100.
34. Czermin B, Melfi R, McCabe D, Seitz V, Imhof A, Pirrotta V. Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites. Cell 2002;111: 185-96.
35. Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial- mesenchymal transition. Nat Cell Biol 2004;6: 931-40.
36. Dar AA, Belkhiri A, El-Rifai W. The aurora kinaseAregulates GSK-3beta in gastric cancer cells. Oncogene 2009;28: 866-75.
37. Miura M, Miura Y, Padilla-Nash HM, Molinolo AA, Fu B, Patel V, et al. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 2006;24: 1095-03.
38. Shiras A, Chettiar ST, Shepal V, Rajendran G, Prasad GR, Shastry P. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma. Stem Cells 2007;25: 1478-89.
39. Liang Y, Zhong Z, Huang Y, Deng W, Cao J, Tsao G, et al. Stem-like cancer cells are inducible by increasing genomic instability in cancer cells. J Biol Chem 2010;285: 4931-40.
40. Dar AA, Goff LW, Majid S, Berlin J, El-Rifai W. Aurora kinase inhibitorsrising stars in cancer therapeutics? Mol Cancer Ther 2010;9: 268-78.
41. Han H, Von Hoff DD. Aurora sheds light on head and neck squamous cell carcinoma. Clin Cancer Res 2006;12: 5003-4.
42. Rybak A, Fuchs H, Smirnova L, Brandt C, Pohl EE, Nitsch R, et al. A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat Cell Biol 2008;10: 987-93.
43. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, et al. let-7 Regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007;131: 1109-23.